Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates

Journal of Clinical Microbiology

Volumn 36, Issue 6, 1998, Pages 1518-1529

  Pfaller, M A ^a   Lockhart, S R ^b   Pujol, C ^b   Swails Wenger, J A ^b   Messer, S A ^a   Edmond, M B ^c   Jones, R N ^a   Wenzel, R P ^c   Soll, D R ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; DNA FINGERPRINTING; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

CANDIDA; CANDIDA ALBICANS;

EID: 0031958444     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.6.1518-1529.1998     Document Type: Article

References (37)

1. Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24:1122-1128.
2. Anderson, J., T. Srikantha, B. Morrow, S. Miyasaki, T. White, N. Agabian, J. Schmid, and D. Soll. 1993. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J. Clin. Microbiol. 31:1472-1480.
3. Backeljau, T., L. De Bruyn, H. De Wolf, K. Jordaens, S. Van Dongen, and B. Winnepenninckx. 1996. Multiple UPGMA and neighbor-joining trees and the performance of some computer packages. Mol. Biol. Evol. 13:309-313.
4. Banerjee, S., T. Emori, D. Culver, R. Gaynes, W. Jarvis, T. Horan, J. Edwards, J. Tolson, T. Henderson, and W. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med. 91:86S-89S.
5. Clemons, K., F. Feroze, K. Holmberg, and D. Stevens. 1997. Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods. J. Clin. Microbiol. 35:1332-1336.
6. Emori, T., and R. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6: 428-442.
7. Fridkin, S., and W. Jarvis. 1996. Epidemiology of nosocomial fungal. Clin. Microbiol. Rev. 9:499-511.
8. Joly, S., C. Pujol, K. Schroppel, and D. Soll. 1996. Development of two species-specific fingerprinting probes for broad computer-assisted epidemiological studies of Candida tropicalis. J. Clin. Microbiol. 34:3063-3071.
9. Joly, S., M. Pfaller, F. Odds and D. Soll. Unpublished data.
10. Lockhart, S., J. Fritch, A. Meier, K. Schroppel, S. Srikantha, R. Galask, and D. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Microbiol. 33: 1501-1509.
11. Lockhart, S., B. Reed, C. Pierson, and D. Soll. 1996. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstrated by sequential DNA fingerprinting with probes Ca3, C1, and CARE2. J. Clin. Microbiol. 34:767-777.
12. Lockhart, S., S. Joly, C. Pujol, J. Sobel, M. Pfaller, and D. Soll. 1997. Development and verification of fingerprinting probes for Candida glabrata. Microbiology 143:3733-3746.
13. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Nguyen, M., J. Peacock, A. Morris, D. Tanner, M. Nguyen, D. R. Snydman, M. Wagener, M. Rinaldi, and V. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
15. Odds, F. 1988. Candida and candidosis: a review and bibliography. Bailliere Tindall, London, United Kingdom.
16. Pfaller, M. 1995. Epidemiology of candidiasis. J. Hosp. Infect. 30(Suppl.): 329-338.
17. Pfaller, M. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22(Suppl.):589-594.
18. Pfaller, M., J. Rex, and M. Rinaldi. 1997. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin. Infect. Dis. 24: 776-784.
19. Pfaller, M. A., S. A. Messer, M. B. Edmond, R. N. Jones, and R. P. Pfaller. Unpublished observations.
20. Price, M., M. LaRocco, and L. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38:1422-1427.
21. Pujol, C., S. Joly, S. Lockhart, S. Noel, M. Tibayrenc, and D. Soll. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35:2348-2358.
22. Rex, J., M. Rinaldi, and M. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
23. Rex, J., M. Pfaller, J. Galgiani, M. Bartlett, I. Espinel, M. Ghannoum, M. Lancaster, F. Odds, M. Rinaldi, T. Walsh, and A. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole. itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin. Infect. Dis. 24:235-247.
24. Rosner, B. 1995. Fundamentals of biostatistics. Duxbury Press, Belmont, Calif.
25. Sadhu, C., M. McEachern, B. Rustchenko, J. Schmid, D. Soll, and J. Hicks. 1991. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification. J. Bacteriol. 173:842-850.
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Schaberg, D., D. Culver, and R. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:72S-75S.
28. Scherer, S., and D. Stevens. 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol. 25:675-679.
29. Schmid, J., M. Rotman, B. Reed, C. Pierson, and D. Soll. 1993. Genetic similarity of Candida albicans isolates from vaginitis patients and their partners. J. Clin. Microbiol. 31:39-46.
30. Schmid, J., E. Voss, and D. Soll. 1990. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J. Clin. Microbiol. 28:1236-1243.
31. Schroeppel, K., M. Rotman, R. Galask, K. Mac, and D. Soll. 1995. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J. Clin. Microbiol. 32:2646-2654.
32. Sneath, P., and R. Sokal. 1973. Numerical taxonomy. The principles and practice of numerical classification. W. H. Freeman & Co., San Francisco, Calif.
33. Soll, D., and R. Galask. Unpublished observations.
34. Soll, D., C. Langtimm, J. McDowell, J. Hicks, and R. Galask. 1987. High-frequency switching in Candida strains isolated from vaginitis patients. J. Clin. Microbiol. 25:1611-1622.
35. Soll, D., R. Galask, J. Schmid, C. Hanna, K. Mac, and B. Morrow. 1991. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29: 1702-1710.
36. Soll, D. R. 1993. DNA fingerprinting of Candida albicans. J. Mycol. Med. 3: 37-14.
37. Wey, S., M. Mori, M. Pfaller, R. Woolson, and R. Wenzel. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353.